keyword
https://read.qxmd.com/read/38551930/a-novel-micellular-fluorogenic-substrate-for-quantitating-the-activity-of-1-phosphatidylinositol-4-5-bisphosphate-phosphodiesterase-gamma-plc%C3%AE-enzymes
#1
JOURNAL ARTICLE
Ramya Visvanathan, Tadanobu Utsuki, Daniel E Beck, W Brent Clayton, Emma Lendy, Kuai-Lin Sun, Yinghui Liu, Kirk W Hering, Andrew Mesecar, Zhong-Yin Zhang, Karson S Putt
The activities of the phospholipase C gamma (PLCγ) 1 and 2 enzymes are essential for numerous cellular processes. Unsurprisingly, dysregulation of PLCγ1 or PLCγ2 activity is associated with multiple maladies including immune disorders, cancers, and neurodegenerative diseases. Therefore, the modulation of either of these two enzymes has been suggested as a therapeutic strategy to combat these diseases. To aid in the discovery of PLCγ family enzyme modulators that could be developed into therapeutic agents, we have synthesized a high-throughput screening-amenable micellular fluorogenic substrate called C16CF3-coumarin...
2024: PloS One
https://read.qxmd.com/read/38539573/synthetic-circular-rna-for-microrna-1269a-suppresses-tumor-progression-in-oral-squamous-cell-carcinoma
#2
JOURNAL ARTICLE
Atsushi Kasamatsu, Ryunosuke Nozaki, Kohei Kawasaki, Tomoaki Saito, Chikashi Minemura, Naohiko Seki, Joel Moss, Katsuhiro Uzawa
microRNAs (miRs) function in cancer progression as post-transcriptional regulators. We previously reported that endogenous circular RNAs (circRNAs) function as efficient miR sponges and could act as novel gene regulators in oral squamous cell carcinoma (OSCC). In this study, we carried out cellular and luciferase reporter assays to examine competitive inhibition of miR-1269a, which is upregulated expression in several cancers, by circRNA-1269a, a synthetic circRNA that contains miR-1269a binding sequences. We also used data-independent acquisition (DIA) proteomics and in silico analyses to determine how circRNA-1269a treatment affects molecules downstream of miR-1269a...
March 21, 2024: Cancers
https://read.qxmd.com/read/38339201/nuclear-binding-protein-2-nesfatin-1-affects-trophoblast-cell-fusion-during-placental-development-via-the-egfr-plcg1-camk4-pathway
#3
JOURNAL ARTICLE
Qinyu Dang, Yandi Zhu, Yadi Zhang, Zhuo Hu, Yuchen Wei, Zhaoyang Chen, Xinyin Jiang, Xiaxia Cai, Huanling Yu
Previous studies have shown that nuclear binding protein 2 ( NUCB2 ) is expressed in the human placenta and increases with an increase in the syncytialization of trophoblast cells. This study aimed to investigate the role of NUCB2 in the differentiation and fusion of trophectoderm cells. In this study, the expression levels of NUCB2 and E-cadherin in the placentas of rats at different gestation stages were investigated. The results showed that there was an opposite trend between the expression of placental NUCB2 and E-cadherin in rat placentas in different trimesters...
February 5, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38106102/multi-omics-analyses-reveal-novel-effects-of-plc%C3%AE-2-deficiency-in-the-mouse-brain
#4
Sarah C Hopp, Juliet Garcia Rogers, Sabrina Smith, Gabriela Campos, Henry Miller, Savannah Barannikov, Eduardo Gutierrez Kuri, Hu Wang, Xianlin Han, Kevin F Bieniek, Susan T Weintraub, Juan Pablo Palavicini
UNLABELLED: Phospholipase C gamma-2 (PLCγ2) catalyzes the hydrolysis of the membrane phosphatidylinositol-4,5-bisphosphate (PIP 2 ) to form diacylglycerol (DAG) and inositol trisphosphate (IP 3 ), which subsequently feed into numerous downstream signaling pathways. PLCG2 polymorphisms are associated with both reduced and increased risk of Alzheimer's disease (AD) and with longevity. In the brain, PLCG2 is highly expressed in microglia, where it is proposed to regulate phagocytosis, secretion of cytokines/chemokines, cell survival and proliferation...
December 8, 2023: bioRxiv
https://read.qxmd.com/read/38061598/the-hypermorphic-plc%C3%AE-2-s707y-variant-dysregulates-microglial-cell-function-insight-into-plc%C3%AE-2-activation-in-brain-health-and-disease-and-opportunities-for-therapeutic-modulation
#5
JOURNAL ARTICLE
Daniel Bull, Julie C Matte, Carmen M Navarron, Rebecca McIntyre, Paul Whiting, Matilda Katan, Fiona Ducotterd, Lorenza Magno
Phospholipase C-gamma 2 (PLCγ2) is highly expressed in hematopoietic and immune cells, where it is a key signalling node enabling diverse cellular functions. Within the periphery, gain-of-function (GOF) PLCγ2 variants, such as the strongly hypermorphic S707Y, cause severe immune dysregulation. The milder hypermorphic mutation PLCγ2 P522R increases longevity and confers protection in central nervous system (CNS) neurodegenerative disorders, implicating PLCγ2 as a novel therapeutic target for treating these CNS indications...
December 5, 2023: Biochimica et Biophysica Acta. Molecular Basis of Disease
https://read.qxmd.com/read/38010137/c-type-lectin-like-receptor-2-clec-2-is-a-key-regulator-of-kappa-carrageenan-induced-tail-thrombosis-model-in-mice
#6
JOURNAL ARTICLE
Ryohei Yokomori, Toshiaki Shirai, Nagaharu Tsukiji, Saori Oishi, Tomoyuki Sasaki, Katsuhiro Takano, Katsue Suzuki-Inoue
Kappa-carrageenan (KCG), which is used to induce thrombosis in laboratory animals for antithrombotic drug screening, can trigger platelet aggregation. However, the cell-surface receptor and related signaling pathways remain unclear. In this study, we investigated the molecular basis of KCG-induced platelet activation using light-transmittance aggregometry, flow cytometry, western blotting, and surface plasmon resonance assays using platelets from platelet receptor-deficient mice and recombinant proteins. KCG-induced tail thrombosis was also evaluated in mice lacking the platelet receptor...
December 2023: Platelets
https://read.qxmd.com/read/37989267/phospholipase-c-%C3%AE-as-a-potential-therapeutic-target-for-graves-orbitopathy
#7
JOURNAL ARTICLE
Tae Hoon Roh, Min Kyung Chae, Jae Sang Ko, Don O Kikkawa, Sun Young Jang, Jin Sook Yoon
BACKGRUOUND: Phospholipase C-γ (PLC-γ) plays a crucial role in immune responses and is related to the pathogenesis of various inflammatory disorders. In this study, we investigated the role of PLC-γ and the therapeutic effect of the PLC-specific inhibitor U73122 using orbital fibroblasts from patients with Graves' orbitopathy (GO). METHODS: The expression of phospholipase C gamma 1 (PLCG1) and phospholipase C gamma 2 (PLCG2) was evaluated using polymerase chain reaction in GO and normal orbital tissues/fibroblasts...
December 2023: Endocrinology and Metabolism
https://read.qxmd.com/read/37880612/efr3a-a-new-raft-domain-organizing-protein
#8
JOURNAL ARTICLE
Magdalena Trybus, Anita Hryniewicz-Jankowska, Karolina Wójtowicz, Tomasz Trombik, Aleksander Czogalla, Aleksander F Sikorski
BACKGROUND: Membrane rafts play a crucial role in the regulation of many important biological processes. Our previous data suggest that specific interactions of flotillins with MPP1 are responsible for membrane raft domain organization and regulation in erythroid cells. Interaction of the flotillin-based protein network with specific membrane components underlies the mechanism of raft domain formation and regulation, including in cells with low expression of MPP1. METHODS: We sought to identify other flotillin partners via the immobilized recombinant flotillin-2-based affinity approach and mass spectrometry technique...
October 25, 2023: Cellular & Molecular Biology Letters
https://read.qxmd.com/read/37769878/plcg2-associated-immune-dysregulation-plaid-comprises-broad-and-distinct-clinical-presentations-related-to-functional-classes-of-genetic-variants
#9
JOURNAL ARTICLE
Kathleen Baysac, Guangping Sun, Hiroto Nakano, Elizabeth G Schmitz, Anthony C Cruz, Charles Fisher, Alexis C Bailey, Emily Mace, Joshua D Milner, Michael J Ombrello
BACKGROUND: Pathogenic variants of phospholipase C gamma 2 (PLCG2) cause 2 related forms of autosomal-dominant immune dysregulation (ID), PLCγ2-associated antibody deficiency and immune dysregulation (PLAID) and autoinflammatory PLAID (APLAID). Since describing these conditions, many PLCG2 variants of uncertain significance have been identified by clinical sequencing of patients with diverse features of ID. OBJECTIVE: We sought to functionally classify PLCG2 variants and explore known and novel genotype-function-phenotype relationships...
January 2024: Journal of Allergy and Clinical Immunology
https://read.qxmd.com/read/37735104/bruton-s-tyrosine-kinase-inhibitors-with-distinct-binding-modes-reveal-differential-functional-impact-on-b-cell-receptor-signaling
#10
JOURNAL ARTICLE
Wei Li, Renata Sano, Mutiah Apatira, Felix DeAnda, Tarikere Gururaja, Muhua Yang, Greta Lundgaard, Chin Pan, Jing Liu, Yongjiao Zhai, Woo Hyun Yoon, Longcheng Wang, Chris Tse, Andrew J Souers, Chih-Hung Lee
Small molecule inhibitors of Bruton's tyrosine kinase (BTK) have been approved for the treatment of multiple B-cell malignancies and are being evaluated for autoimmune and inflammatory diseases. Various BTK inhibitors (BTKis) have distinct potencies, selectivity profiles, and binding modes within the ATP-binding site. Based on the latter feature, BTKis can be classified into those that occupy the back-pocket, H3 pocket, and the hinge region only. Hypothesizing that differing binding modes may have differential impact on the B-cell receptor (BCR) signaling pathway, we evaluated the activities of multiple BTKis in B-cell lymphoma models in vitro and in vivo...
September 21, 2023: Molecular Cancer Therapeutics
https://read.qxmd.com/read/37659412/genetic-variants-of-phospholipase-c-%C3%AE-2-alter-the-phenotype-and-function-of-microglia-and-confer-differential-risk-for-alzheimer-s-disease
#11
JOURNAL ARTICLE
Andy P Tsai, Chuanpeng Dong, Peter Bor-Chian Lin, Adrian L Oblak, Gonzalo Viana Di Prisco, Nian Wang, Nicole Hajicek, Adam J Carr, Emma K Lendy, Oliver Hahn, Micaiah Atkins, Aulden G Foltz, Jheel Patel, Guixiang Xu, Miguel Moutinho, John Sondek, Qisheng Zhang, Andrew D Mesecar, Yunlong Liu, Brady K Atwood, Tony Wyss-Coray, Kwangsik Nho, Stephanie J Bissel, Bruce T Lamb, Gary E Landreth
Genetic association studies have demonstrated the critical involvement of the microglial immune response in Alzheimer's disease (AD) pathogenesis. Phospholipase C-gamma-2 (PLCG2) is selectively expressed by microglia and functions in many immune receptor signaling pathways. In AD, PLCG2 is induced uniquely in plaque-associated microglia. A genetic variant of PLCG2, PLCG2P522R , is a mild hypermorph that attenuates AD risk. Here, we identified a loss-of-function PLCG2 variant, PLCG2M28L , that confers an increased AD risk...
August 29, 2023: Immunity
https://read.qxmd.com/read/37432929/a-novel-in-vitro-model-to-study-prolonged-pseudomonas-aeruginosa-infection-in-the-cystic-fibrosis-bronchial-epithelium
#12
JOURNAL ARTICLE
Meghan J Hirsch, Emily M Hughes, Molly M Easter, Seth E Bollenbecker, Patrick H Howze Iv, Susan E Birket, Jarrod W Barnes, Megan R Kiedrowski, Stefanie Krick
Pseudomonas aeruginosa (PA) is known to chronically infect airways of people with cystic fibrosis (CF) by early adulthood. PA infections can lead to increased airway inflammation and lung tissue damage, ultimately contributing to decreased lung function and quality of life. Existing models of PA infection in vitro commonly utilize 1-6-hour time courses. However, these relatively early time points may not encompass downstream airway cell signaling in response to the chronic PA infections observed in people with cystic fibrosis...
2023: PloS One
https://read.qxmd.com/read/37197640/proteomic-portrait-of-human-lymphoma-reveals-protein-molecular-fingerprint-of-disease-specific-subtypes-and-progression
#13
JOURNAL ARTICLE
Xin Ku, Jinghan Wang, Haikuo Li, Chen Meng, Fang Yu, Wenjuan Yu, Zhongqi Li, Ziqi Zhou, Can Zhang, Ying Hua, Wei Yan, Jie Jin
UNLABELLED: An altered proteome in lymph nodes often suggests abnormal signaling pathways that may be associated with diverse lymphatic disorders. Current clinical biomarkers for histological classification of lymphomas have encountered many discrepancies, particularly for borderline cases. Therefore, we launched a comprehensive proteomic study aimed to establish a proteomic landscape of patients with various lymphatic disorders and identify proteomic variations associated with different disease subgroups...
April 2023: Phenomics
https://read.qxmd.com/read/37082661/the-inhibitory-effect-of-isoliquiritigenin-on-human-platelets-in-vitro
#14
JOURNAL ARTICLE
Yingying Wu, Cheng Deng, Yixuan Wang, Zhangyin Ming, Heng Mei, Yu Hu
BACKGROUND: Platelets play important roles in several physiological and pathological processes. Multiple antiplatelet drugs have been developed for clinical practice. The active components of traditional Chinese medicine with antithrombotic effects are promising drugs to modulate platelet function. In our study, the antiplatelet effect of isoliquiritigenin (ILTG) and its mechanisms were examined. METHODS: Human platelet-rich plasma and a washed platelet suspension were prepared...
March 31, 2023: Annals of Translational Medicine
https://read.qxmd.com/read/37081539/carriers-of-the-p-p522r-variant-in-plc%C3%AE-2-have-a-slightly-more-responsive-immune-system
#15
JOURNAL ARTICLE
Annieck M Diks, Cristina Teodosio, Bas de Mooij, Rick J Groenland, Brigitta A E Naber, Inge F de Laat, Sandra A Vloemans, Susan Rohde, Marien I de Jonge, Linda Lorenz, Debbie Horsten, Jacques J M van Dongen, Magdalena A Berkowska, Henne Holstege
BACKGROUND: The rs72824905 single-nucleotide polymorphism in the PLCG2 gene, encoding the p.P522R residue change in Phospholipase C gamma 2 (PLCγ2), associates with protection against several dementia subtypes and with increased likelihood of longevity. Cell lines and animal models indicated that p.P522R is a functional hypermorph. We aimed to confirm this in human circulating peripheral immune cells. METHODS: We compared effects of p.P522R on immune system function between carriers and non-carriers (aged 59-103y), using in-depth immunophenotyping, functional B-cell and myeloid cell assays, and in vivo SARS-CoV-2 vaccination...
April 20, 2023: Molecular Neurodegeneration
https://read.qxmd.com/read/36997670/g-csf-drives-autoinflammation-in-aplaid
#16
JOURNAL ARTICLE
Elisabeth Mulazzani, Klara Kong, Juan I Aróstegui, Ashley P Ng, Nishika Ranathunga, Waruni Abeysekera, Alexandra L Garnham, Sze-Ling Ng, Paul J Baker, Jacob T Jackson, John D Lich, Margaret L Hibbs, Ian P Wicks, Cynthia Louis, Seth L Masters
Missense mutations in PLCG2 can cause autoinflammation with phospholipase C gamma 2-associated antibody deficiency and immune dysregulation (APLAID). Here, we generated a mouse model carrying an APLAID mutation (p.Ser707Tyr) and found that inflammatory infiltrates in the skin and lungs were only partially ameliorated by removing inflammasome function via the deletion of caspase-1. Also, deleting interleukin-6 or tumor necrosis factor did not fully prevent APLAID mutant mice from autoinflammation. Overall, these findings are in accordance with the poor response individuals with APLAID have to treatments that block interleukin-1, JAK1/2 or tumor necrosis factor...
May 2023: Nature Immunology
https://read.qxmd.com/read/36933698/a-novel-fluorogenic-reporter-substrate-for-1-phosphatidylinositol-4-5-bisphosphate-phosphodiesterase-gamma-2-plc%C3%AE-2-application-to-high-throughput-screening-for-activators-to-treat-alzheimer-s-disease
#17
JOURNAL ARTICLE
Ramya Visvanathan, Tadanobu Utsuki, Daniel E Beck, Emma Lendy, Kuai-Lin Sun, Yinghui Liu, Kirk W Hering, Andrew Mesecar, Zhong-Yin Zhang, Karson S Putt
A rare coding variant in PLCγ2 (P522R) expressed in microglia induces a mild activation of enzymatic activity when compared to wild-type. This mutation is reported to be protective against cognitive decline associated with late-onset Alzheimer's disease (LOAD) and therefore, activation of wild-type PLCγ2 has been suggested as a potential therapeutic target for the prevention and treatment of LOAD. Additionally, PLCγ2 has been associated with other diseases such as cancer and some autoimmune disorders where mutations with much greater increases in PLCγ2 activity have been identified...
March 16, 2023: SLAS Discovery
https://read.qxmd.com/read/36911665/bruton-s-tyrosine-kinase-inhibition-attenuates-disease-progression-by-reducing-renal-immune-cell-invasion-in-mice-with-hemolytic-uremic-syndrome
#18
JOURNAL ARTICLE
Sarah Kröller, Bianka Wissuwa, Sophie Dennhardt, Nadine Krieg, Christoph Thiemermann, Christoph Daniel, Kerstin Amann, Florian Gunzer, Sina M Coldewey
Hemolytic-uremic syndrome (HUS) can occur as a complication of an infection with Shiga-toxin (Stx)-producing Escherichia coli . Patients typically present with acute kidney injury, microangiopathic hemolytic anemia and thrombocytopenia. There is evidence that Stx-induced renal damage propagates a pro-inflammatory response. To date, therapy is limited to organ-supportive strategies. Bruton's tyrosine kinase (BTK) plays a pivotal role in recruitment and function of immune cells and its inhibition was recently shown to improve renal function in experimental sepsis and lupus nephritis...
2023: Frontiers in Immunology
https://read.qxmd.com/read/36594740/the-chaperone-assisted-selective-autophagy-complex-dynamics-and-dysfunctions
#19
JOURNAL ARTICLE
Barbara Tedesco, Leen Vendredy, Vincent Timmerman, Angelo Poletti
Each protein must be synthesized with the correct amino acid sequence, folded into its native structure, and transported to a relevant subcellular location and protein complex. If any of these steps fail, the cell has the capacity to break down aberrant proteins to maintain protein homeostasis (also called proteostasis). All cells possess a set of well-characterized protein quality control systems to minimize protein misfolding and the damage it might cause. Autophagy, a conserved pathway for the degradation of long-lived proteins, aggregates, and damaged organelles, was initially characterized as a bulk degradation pathway...
January 3, 2023: Autophagy
https://read.qxmd.com/read/36382045/identification-of-lipid-regulatory-genes-modulated-by-polyherbal-formulation-in-chicken-liver-tissues-using-transcriptome-analysis
#20
JOURNAL ARTICLE
Saravanakumar Marimuthu, Subramaniyam Suresh, Prashanth D'Souza
Objective: To elucidate the cellular mechanisms of polyherbal formulation [Kolin PlusTM (KP)], genomics was performed to delineate the genes and pathways associated with lipid regulation through transcriptional profiling of the liver in commercial broilers raised on diets deficient in choline chloride (CCL). Materials and Methods: The gene expression patterns were studied for four groups [normal diet: normal, choline chloride deficient (CCD), KP (400 gm/ton), and CCL (400 gm/ton)] using Agilent microarray on day 42...
September 2022: Journal of Advanced Veterinary and Animal Research
keyword
keyword
60233
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.